XBiotech Inc. XBIT
Set alert
1.88 USD -0.06 -3.09%
At close · Oct 30
1.88 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.87 Day range 1.98
1.85 52-week range 2.94
- YTD
- -21.34%
- 1 year
- -21.67%
- Open
- 1.94
- Prev close
- 1.94
- Mkt cap
- 57.32M
- Vol
- 50.56K
- Avg vol
- 55.49K
- EPS
- -1.48
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.87
- High
- 1.98
- Forward P/E
- 34.62
- Beta
- 0.00
- Short ratio
- 15.03
- Inst. own
- 16.19%
- Dividend
- 0.00
- Ex-div date
- Jul 14, 2021
- Earnings
- Nov 9, 2023
- 50-d avg
- 7.07
- 200-d avg
- 7.11
- 1y target
- 0.00
Financial health
Altman Z-Score
4.98 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -1.6×
FY 2016 5y median -3.2× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.5×
FY 2016 5y median 0.6× FY 2025
P/FCF -1.8×
FY 2016 5y median -3.7× FY 2025
EV/EBITDA 1.2×
FY 2016 5y median 1.2× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -55.2%
FY 2016 5y median -15.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -32.4%
FY 2016 5y median -13.7% FY 2025
ROIC -39.2%
FY 2016 5y median -17.0% FY 2025
ROA -30.3%
FY 2016 5y median -13.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -31.1%
FY 2016 FY 2025
EPS (diluted) -18.3%
FY 2016 FY 2025
Free Cash Flow -24.6%
FY 2016 FY 2025
Financial Health
Current Ratio 16.0×
FY 2016 5y median 33.1× FY 2025
Quick Ratio 16.0×
FY 2016 5y median 33.1× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 2.9×
FY 2016 5y median 5.1× FY 2025
Interest Coverage -633×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31